Pfizer’s Pipeline Plan

[cnbc 3000087156]

Catherine Arnold, senior analyst at Credit Suisse, discusses her company’s “buy” rating on Pfizer ahead of the company’s Q1 earnings report.

Melissa Lee anchors a fast-paced discussion among four professional Wall Street traders. An hour after the bell Fast Money hosts one of the best trading discussions of the day.

Video © and provided by CNBC.

Be the first to comment

Leave a Reply